| pubmed-article:10458234 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10458234 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:10458234 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10458234 | lifeskim:mentions | umls-concept:C0023452 | lld:lifeskim |
| pubmed-article:10458234 | lifeskim:mentions | umls-concept:C0149615 | lld:lifeskim |
| pubmed-article:10458234 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
| pubmed-article:10458234 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10458234 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:10458234 | pubmed:dateCreated | 1999-9-3 | lld:pubmed |
| pubmed-article:10458234 | pubmed:abstractText | A retrospective analysis of the treatment of childhood acute lymphoblastic leukemia (ALL) in second remission (CR2) was undertaken at our institution to compare the outcome and prognostic factors of patients treated with chemotherapy or allogeneic bone marrow transplantation (BMT). | lld:pubmed |
| pubmed-article:10458234 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458234 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10458234 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458234 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10458234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458234 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10458234 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:10458234 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:O'ReillyR JRJ | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:ReyesBB | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:HellerGG | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:GillioA PAP | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:SteinherzPP | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:KernanN ANA | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:BrochsteinJ... | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:SmallT NTN | lld:pubmed |
| pubmed-article:10458234 | pubmed:author | pubmed-author:BouladFF | lld:pubmed |
| pubmed-article:10458234 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10458234 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:10458234 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10458234 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10458234 | pubmed:pagination | 197-207 | lld:pubmed |
| pubmed-article:10458234 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:meshHeading | pubmed-meshheading:10458234... | lld:pubmed |
| pubmed-article:10458234 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10458234 | pubmed:articleTitle | Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. | lld:pubmed |
| pubmed-article:10458234 | pubmed:affiliation | Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. bouladf@mskcc.org | lld:pubmed |
| pubmed-article:10458234 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10458234 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10458234 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10458234 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458234 | lld:pubmed |
